Development and Testing of Novel Metabolic Interventions for Severe Mental Illness 

Working closely with the James Lind alliance and The McPin Foundation, this workstream will co-develop and assess the acceptability and therapeutic potential of a range of metabolic interventions as novel treatments for severe mental illness including digital approaches, chrononutrition (time restricted eating), the ketogenic diet, low carb diets, metformin and GLP1 receptor antagonists. This work will prioritise and co-design future clinical trials of metabolic interventions for SMI.

​

​